Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

21 events

Tuesday, January 22nd: 8:00 - 9:30, Room 1 - Main Arena 1

Symposium: Keep on walking: Steps towards successfull PAD treatment

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Thomas Zeller, Jonathan Sobocinski, Koen Deloose, Jörg Teßarek, Shannon Thomas
1. 08:00 - 08:07
  
  Step by step SFA/pop treatment algorithm
2. 08:07 - 08:14
  
  Step by step selection algorithm and clinical decision making through OCT technology
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Supera CFA VMI 1-year follow-up results
5. 08:52 - 08:59
  
  Supera in AVF management and 1-year outcomes
6. 08:59 - 09:06
  
  Supera in popliteal aneurysm, proof of concept, and clinical outcomes
7. 09:06 - 09:30
  
  Live case transmission from Leipzig
Tuesday, January 22nd: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: See clearly, treat optimally: image guided therapy on the rise

supported with an educational grant from Philips

Moderator:

Dierk Scheinert, Frans Moll

Panel:

Constantino Peña, Jim A. Reekers, Fabrizio Fanelli, Maria Louisa Izamis
1. 09:30 - 09:35
  
  Introduction and learning objectives
2. 09:35 - 09:49
  
  Next generation pan-vascular suite: optimizing patient management and outcomes
3. 09:49 - 09:57
  
  Perfusion angiography for optimizing planning and treatment of diabetic foot
4. 09:57 - 10:17
  
  BTK recorded case presentation
5. 10:17 - 10:25
  
  Role of IVUS within a “treat optimally” algorithm of care
6. 10:25 - 10:35
  
  Innovations at the forefront: a glance at the future of image guided therapy
7. 10:35 - 10:55
  
  Live case transmission from Leipzig
8. 10:55 - 11:00
  
  Q&A and conclusion
Tuesday, January 22nd: 11:00 - 12:15, Room 1 - Main Arena 1

Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

Moderator:

Dierk Scheinert, John Laird

Panel:

Konstantinos Katsanos, Peter Schneider, Michael Dake, Thomas Zeller, William Gray, Sean Lyden
1. 11:00 - 11:10
  
  Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs
2. 11:10 - 11:16
  
  A look into the methods: merits and limits of meta-analysis
3. 11:16 - 11:22
  
  Toxicological aspects and safety profile of Paclitaxel
4. 11:22 - 11:28
  
  Event adjudication in clinical trials: how does it work?
5. PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES
6. 11:28 - 11:33
  
  DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme
7. 11:33 - 11:38
  
  Long-term safety data of the Lutonix DCB formulation
8. 11:38 - 11:43
  
  Long-term safety data from the Stellarex DCB programme
9. 11:43 - 11:48
  
  Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme
10. 11:48 - 11:53
  
  Patient safety in the Eluvia-DES and Ranger DCB programme
11. 11:53 - 12:00
  
  How to proceed to generate more evidence on patient safety with drug-eluting devices
12. 12:00 - 12:15
  
  Podium discussion
Tuesday, January 22nd: 12:15 - 13:30, Room 1 - Main Arena 1

“To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

Moderator:

Dierk Scheinert, William Gray

Panel:

Osamu Iida, Gunnar Tepe, Hiroyoshi Yokoi
1. FOCUS ON NEW DATA ON DRUG-COATED BALLOONS
2. 12:15 - 12:20
  
  First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan
3. 12:20 - 12:25
  
  First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?
4. 12:25 - 12:30
  
  First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials
5. 12:30 - 12:35
  
  First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
6. 12:35 - 12:40
  
  First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions
7. 12:40 - 12:45
  
  First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-month results of the BIOLUX P-III full cohort
8. 12:45 - 12:50
  
  DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series
9. 12:50 - 12:55
  
  Stellarex in real world: Interim look from the SAVER registry
10. FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS
11. 12:55 - 13:00
  
  First time data release: Final 12-month results of the Zilverpass-RCT of Zilver PTX vs. bypass
12. 13:00 - 13:05
  
  TOBA II Trial (Lutonix or POBA + Tack) – 1-year results
13. 13:05 - 13:10
  
  First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents
14. 13:10 - 13:15
  
  First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents
15. 13:15 - 13:20
  
  First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease
16. 13:20 - 13:25
  
  The Illumina FIH study with a next generation DES – 12-month results
17. 13:25 - 13:30
  
  Discussion and conclusion
Tuesday, January 22nd: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

sponsored by Medtronic

Moderator:

Dierk Scheinert

Panel:

John Laird, Theodosios Bisdas, Konstantinos Stavroulakis, Jos van den Berg
1. 13:30 - 13:38
  
  Endovascular lessons learned in the last decade: what are the remaining challenges?
2. 13:38 - 14:02
  
  Live case transmission from Leipzig
3. 14:02 - 14:10
  
  Long lesions: primary stenting or DCB first?
4. 14:10 - 14:18
  
  Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?
5. 14:18 - 14:42
  
  Live case transmission from New York
6. 14:42 - 14:49
  
  Dissections: prevent, minimize, or repair
7. 14:49 - 15:00
  
  Discussion and conclusion
Tuesday, January 22nd: 15:00 - 16:30, Room 1 - Main Arena 1

Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

supported with an educational grant from Boston Scientific

Moderator:

Stephen Black

Panel:

Mahmood Razavi, Michael Lichtenberg, Luis Izquierdo, Lowell Kabnick
1. 15:00 - 15:05
  
  Welcome and introduction
2. 15:05 - 15:20
  
  VIRTUS: Trial design and primary endpoint results
3. 15:20 - 15:35
  
  VICI VENOUS STENT: Design attributes & patient outcome
4. 15:35 - 15:40
  
  Panel discussion and questions
5. 15:40 - 15:50
  
  Complexities of chronic venous disease
6. 15:50 - 16:00
  
  Imaging, its central role in planning and guiding intervention
7. 16:00 - 16:20
  
  Live case transmission from Galway
8. 16:20 - 16:30
  
  Panel discussion and questions
Tuesday, January 22nd: 16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for complex femoral lesions and critical limb ischemia

Moderator:

John Laird, Marc Bosiers

Panel:

Jos van den Berg, Yann Gouëffic, Lawrence Garcia, Stefan Müller-Hülsbeck, Brian DeRubertis, Torsten Fuß
1. 16:30 - 16:36
  
  True minimally invasive access strategies for complex peripheral interventions
2. 16:36 - 17:02
  
  Live case transmission from Leipzig
3. 17:02 - 17:07
  
  First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes
4. 17:07 - 17:12
  
  First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series
5. 17:12 - 17:18
  
  IN.PACT Admiral DCB: a look at long lesion outcomes across trials
6. 17:18 - 17:24
  
  From research to practice: how does atherectomy fit in my treatment algorithm
7. 17:24 - 17:50
  
  Live case transmission from New York
8. 17:50 - 17:55
  
  REALITY: Initial experience
9. 17:55 - 18:00
  
  Phoenix atherectomy: technique and real-world evidence
Wednesday, January 23rd: 8:00 - 9:30, Room 1 - Main Arena 1

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on new trials, drug-eluting technologies, and new implants

Moderator:

Dierk Scheinert, Jihad Mustapha

Panel:

Marc Bosiers, Peter Schneider, Ehrin Armstrong, Frank Vermassen, Ramon Varcoe, Francesco Liistro
1. 08:00 - 08:05
  
  Update on the BEST-trial: How will it change our practice
2. 08:05 - 08:10
  
  Endovascular treatment vs. bypass surgery in CLI patients with chronic kidney disease
3. 08:10 - 08:15
  
  First time data release: In depth look at Lutonix safety events with difficult lesion 6-month BTK IDE Update
4. 08:15 - 08:20
  
  First time data release: Interim 24-month results from the global LUTONIX® 014 DCB real world BTK registry
5. 08:20 - 08:25
  
  First time data release: Paclitaxel-coated balloon in below-the-knee lesions: 6-month results from the Ranger BTK single center study
6. 08:25 - 08:30
  
  First time data release: Initial experience with the temporary spur stent system: DEEPER trial first-in-man results
7. 08:30 - 08:35
  
  New DCB era for BTK: 6-month results from the China AcoArt II study
8. 08:35 - 08:40
  
  Drug-coated balloons in BTK: Where do we stand and what are the open questions?
9. 08:40 - 08:45
  
  Alternative methods of drug delivery in BTK vessels – Initial insights from the TANGO trial
10. 08:45 - 09:05
  
  Live case transmission from Leipzig
11. 09:05 - 09:10
  
  How to reduce dissections in BTK: Techniques & devices
12. 09:10 - 09:15
  
  Size matters: experimental study on the effect of oversizing during tibial PTA
13. 09:15 - 09:20
  
  Initial experience with a new 3F compatible microstent for BTK revascularisation
14. 09:20 - 09:25
  
  The demise of the absorb BVS. Why it failed, what we learned from the coronary experience, and is there is a future for bioresorbable scaffolds below-the-knee?
15. 09:25 - 09:30
  
  Discussion and conclusion
Wednesday, January 23rd: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Data supported solutions for peripheral arterial disease intervention

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert, Yann Gouëffic

Panel:

Konstantinos Katsanos, Costantino del Giudice, Stefan Müller-Hülsbeck
1. 09:30 - 09:32
  
  Introduction and learning objectives
2. 09:32 - 09:47
  
  Benchmarking Ranger drug-coated balloon data in SFA treatment
3. 09:47 - 10:02
  
  Downstaging complexity for a DCB strategy in claudicants
4. 10:02 - 10:27
  
  Live case transmission from Leipzig
5. 10:27 - 10:42
  
  Gauging performance in below-the-knee intervention
6. 10:42 - 10:57
  
  Raising the bar with Eluvia drug-eluting stent data
7. 10:57 - 11:00
  
  Close and take aways
Wednesday, January 23rd: 11:00 - 12:30, Room 1 - Main Arena 1

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on imaging, revascularisation strategies, atherectomy, and assessment of results

Moderator:

Peter Schneider, Roberto Ferraresi

Panel:

Jim A. Reekers, Miguel Montero-Baker, George Adams, Yoshimitsu Soga, Marco Manzi
1. 11:00 - 11:05
  
  Critical limb ischemia: Have we made improvement in classifying these patients in a better way?
2. 11:05 - 11:11
  
  Tips and tricks to optimize preinterventional imaging with CO2 angiography and no-contrast MR angiography
3. 11:11 - 11:17
  
  Wound and surgery-guided revascularisation & flow-guided surgery: the multidisciplinary approach to limb salvage
4. 11:17 - 11:23
  
  When is below-the-ankle angioplasty indicated and how to introduce it into your practice?
5. 11:23 - 11:43
  
  Live case transmission from Münster
6. 11:43 - 11:48
  
  How to optimize acute success and drug effect of DCB in BTK vessels?
7. 11:48 - 11:54
  
  The role of orbital atherectomy for optimization of BTK revascularisation results
8. 11:54 - 12:00
  
  Versatility of directional atherectomy: Clinical use below-the-knee
9. 12:00 - 12:06
  
  Assessing foot perfusion after BTK revascularisation: Role of perfusion angiography and upcoming techniques
10. 12:06 - 12:11
  
  Perfusion imaging of the foot in CLI-patients: prognostic value of pharmacological interventions
11. 12:11 - 12:16
  
  Is non-functional microcirculation the same as flow-independent ischemia?
12. 12:16 - 12:30
  
  Discussion and conclusion
Wednesday, January 23rd: 12:30 - 13:30, Room 1 - Main Arena 1

Focus session: Pioneering approaches for “no-option” patients

partially supported with an educational grant from LimFlow

live from Leipzig:

Steven Kum, Andrej Schmidt

Moderator:

Jihad Mustapha, Marianne Brodmann

Panel:

Roberto Ferraresi, Peter Schneider, Ehrin Armstrong
1. Flash presentation: No option CLI – A rising epidemic and an overview of solutions
2. Flash presentation: Surgical and hybrid venous arteriolisation – How to perform it and what are the limitations
3. Flash presentation: Update on the PROMISE I early feasibility study in the US and global experience
4. Flash presentation: Rationale and design of a pivotal study for an autologous blood filter device for treatment of critical limb ischemia
Wednesday, January 23rd: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Lutonix® DCB – The next clinically proven frontier for SFA, BTK, and AV treatment algorithms

supported with an educational grant from C. R. Bard

Moderator:

Dierk Scheinert

Panel:

Koen Deloose, Patrick Geraghty, Aloke Finn, Scott Trerotola, Yoshimitsu Soga
1. 13:30 - 13:40
  
  Global CTO analyses of all Lutonix DCB SFA combined trials
2. 13:40 - 13:50
  
  A closer look at the benefit of LTX DCB in diabetic patient in Japan
3. 13:50 - 14:00
  
  Comparison of overall LTX BTK IDE 6-month outcomes to global registry
4. 14:00 - 14:10
  
  Comparative studies of downstream events with drug coated balloon
5. 14:10 - 14:20
  
  Sub-group analysis from LTX AV randomised trial
6. 14:20 - 14:30
  
  Review and comparisons of DCB global registries
7. 14:30 - 14:55
  
  Live case transmission from Leipzig
8. 14:55 - 15:00
  
  Discussion and conclusion
Wednesday, January 23rd: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Carotid revascularisation redux: A whole new horizon?

Moderator:

Peter Schneider, Chris Metzger

Panel:

Sean Lyden, William Gray, John Laird, Ehrin Armstrong
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Carreer Award 2018
2. 15:05 - 15:30
  
  Live case transmission from Columbus
3. 15:30 - 15:38
  
  Transcervical carotid stenting (TCAR) is a game changer and a re-boot for CAS
4. 15:38 - 15:46
  
  Cognitive decline with untreated carotid lesions: fact or fiction?
5. 15:46 - 15:54
  
  Timing of carotid bifurcation repair after symptoms: how does it affect stroke risk?
6. 15:54 - 16:22
  
  Live case transmission from Columbus
7. 16:22 - 16:30
  
  Will mesh covered stents help reduce the risk of stroke?
Wednesday, January 23rd: 16:30 - 18:00, Room 1 - Main Arena 1

The remaining challenges: Long CTO lesions and in-stent restenosis

Moderator:

Sean Lyden, Ramon Varcoe

Panel:

Michael Dake, Jorge Fernández Noya, Sabine Steiner, Dai-Do Do
1. 16:30 - 16:36
  
  First time data release: Intravascular ultrasound supported endovascular therapy in superficial femoral artery disease: 12-month results from the IVORY-study
2. 16:36 - 16:42
  
  Insights from Global Zilver PTX experience: What are the predictors for clinical failure and TLR?
3. 16:42 - 16:48
  
  CTO vs. non-CTO lesions: What are the lessons learned from the Real-PTX trial and the concept of the BEST-SFA trial?
4. 16:48 - 17:13
  
  Live case transmission from Leipzig
5. 17:13 - 17:19
  
  Complex case review: Versatility of the GORE® VIABAHN® endoprosthesis in the treatment of challenging peripheral disease
6. 17:19 - 17:25
  
  Combination therapy tackling ISR: laser + DCB 2-year results
7. 17:25 - 17:31
  
  Advancing laser therapy: different settings for different lesions
8. 17:31 - 17:56
  
  Live case transmission from Columbus
9. 17:56 - 18:00
  
  Discussion and conclusion
Thursday, January 24th: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Extreme BTK interventions

Moderator:

Chris Metzger, Roberto Ferraresi

Panel:

Robert Beasley, Jihad Mustapha, Wei Guo, Francesco Liistro, Marianne Brodmann, Luis Mariano Palena
1. 08:00 - 08:21
  
  Live case transmission from Abano Terme
2. 08:21 - 08:29
  
  SAD transmission & BAD distribution: who is today a no-option CLI patient?
3. 08:29 - 08:37
  
  Peroneal access technique: How I do it and when do I consider it?
4. 08:37 - 08:45
  
  Calcified below-the-knee lesions – overview of treatment options
5. 08:45 - 09:06
  
  Live case transmission from Leipzig
6. 09:06 - 09:14
  
  An evaluation of drug eluting technologies for BTK treatment
7. 09:14 - 09:22
  
  DCB in BTK: Why and where should we use it
8. 09:22 - 09:30
  
  Prestige pilot: Phoenix atherectomy and Stellarex DCB in infrapopliteal interventions
Thursday, January 24th: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Mechanical atherectomy and thrombectomy of arterial and venous occlusions

supported with an educational grant from Straub Medical

Moderator:

Dierk Scheinert, Romaric Loffroy

Panel:

Bruno Freitas, Christian Wissgott, Michael Lichtenberg
1. 09:30 - 09:40
  
  Atherectomy and thrombectomy of femoropopliteal occlusions with Rotarex ®S: The Leipzig experience
2. 09:40 - 10:10
  
  Live case transmission from Leipzig
3. 10:10 - 10:20
  
  Retrospective analysis of initial results of an atherothrombectomy device in patients with acute, subacute, and chronic lower limb artery occlusion
4. 10:20 - 10:50
  
  Live case transmission from Leipzig
5. 10:50 - 11:00
  
  Safety, procedural success, and outcomes of the Aspirex® S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis: data from the Arnsberg Aspirex registry
Thursday, January 24th: 11:00 - 12:30, Room 1 - Main Arena 1

Endo-vascular transcendence in end stage renal disease

supported with an educational grant from C. R. Bard

Moderator:

Dierk Scheinert

Panel:

Robert Jones, Bart Dolmatch, Panagiotis Kitrou, Roberto Ferraresi, Tobias Steinke, Robert Shahverdyan
1. 11:00 - 11:08
  
  Endovascular therapy first in ESRD
2. 11:08 - 11:16
  
  CLI in ERSD. Upper & lower limb ischemia
3. 11:16 - 11:24
  
  WavelinQ endo-vascular access creation
4. 11:24 - 11:32
  
  Different approaches in WavelinQ endo-vascular access
5. 11:32 - 11:42
  
  Recorded case presentation
6. 11:42 - 11:52
  
  Treating the dysfunctional AV. From algorithm to Tips & Tricks
7. 11:52 - 11:57
  
  Proof is in the evidence
8. 11:57 - 12:22
  
  Live case transmission from Münster
9. 12:22 - 12:30
  
  Discussion and conclusion
Thursday, January 24th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Thursday, January 24th: 13:30 - 15:00, Room 1 - Main Arena 1

The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

Moderator:

Lawrence Garcia, Yann Gouëffic

Panel:

Sebastian Debus, Frank Criado, Erwin Blessing, Matthew Menard, Wei Liang
1. 13:30 - 13:35
  
  Long term (10 years) outcomes using VIABAHN for the treatment of PAA
2. 13:35 - 13:55
  
  Live case transmission from Leipzig
3. LINC STATUS UPDATE: MANAGEMENT OF COMMON FEMORAL DISEASE
4. 13:55 - 14:00
  
  Lesions of the CFA: Increasing evidence for endovascular rather than open repair!
5. 14:00 - 14:05
  
  I disagree: Surgical reconstruction is still the gold standard for CFA reconstruction
6. 14:05 - 14:10
  
  Panel discussion and audience vote
7. 14:10 - 14:35
  
  Live case transmission from Bad Krozingen
8. 14:35 - 14:40
  
  Intravascular Lithotripsy as a treatment option for calcified stenosis of the common femoral artery: initial experiences
9. 14:40 - 14:45
  
  Directional atherectomy and anti-restenotic therapy for CFA disease
10. 14:45 - 14:50
  
  2-year outcomes of directional atherectomy and anti-restenotic therapy in CFA disease
11. 14:50 - 14:55
  
  A valuable alternative for CFA endarterectomy? The use of the Supera vascular mimetic implant for the treatment of atherosclerotic disease in the CFA: 12-month results of the VMI-CFA study
12. 14:55 - 15:00
  
  Bifurcation stenting of the common femoral artery – long term follow up of Supera cases using the Culotte technique
Thursday, January 24th: 15:00 - 18:00, Room 1 - Main Arena 1

Disruptive treatment approaches and pioneering techniques for patients with vascular disease

partially supported with an educational grant from Bayer AG

Moderator:

William Gray, Sebastian Debus

Panel:

Rupert Bauersachs, Marianne Brodmann, George Adams, Ramon Varcoe, Ehrin Armstrong
1. FOCUS ON INNOVATIONS IN DRUG THERAPY
2. 15:00 - 15:08
  
  Understanding the latest evidence with Rivaroxaban vascular dose in PAD treatment
3. 15:08 - 15:16
  
  How can the COMPASS PAD data be applied to daily clinical practice?
4. FOCUS ON INNOVATIONS FOR VESSEL PREPARATION
5. 15:16 - 15:22
  
  What lessons have we learned from DEFINITIVE AR
6. 15:22 - 15:47
  
  Live case transmission from Münster
7. FOCUS ON INNOVATIONS IN IMPLANT TECHNOLOGY
8. 15:47 - 15:53
  
  Future of stenting in the current DCB world
9. 15:53 - 15:59
  
  Interim 2-year results from the MIMICS-2 study
10. 15:59 - 16:21
  
  Live case transmission from Leipzig
11. 16:21 - 16:43
  
  Live case transmission from Bad Krozingen
12. 16:43 - 16:49
  
  Characterizing the relationship between oxygen measured by subcutaneous micorsensors during revascularisation procedures and wound healing in CLI patients
13. 16:49 - 16:55
  
  Update on MIMICS-3D: Emerging real world registry data
14. FOCUS ON INNOVATIONS FOR COMPLEX FEMORAL LESIONS - THE PERCUTANEOUS BYPASS TECHNIQUE
15. 16:55 - 17:01
  
  Taking the scenic route: A complex case from the DETOUR II trial
16. 17:01 - 17:07
  
  First time data release: Extreme SFA lesions: DETOUR I 12-month results in lesions >30cm
17. 17:07 - 17:13
  
  Durability of the DETOUR procedure for percutaneous fem-pop bypass: 3-year follow-up from my first case
18. FOCUS ON STRATEGIES TO OPTIMIZE ASSESSMENT OF REVASCULARISATION RESULTS
19. 17:13 - 17:19
  
  Perfusion angiography: towards new standards for optimized treatment outcomes
20. 17:19 - 17:44
  
  Live case transmission from Abano Terme
21. FOCUS ON VENOUS DISEASE
22. 17:44 - 17:50
  
  Endovenous Valve Formation (EVF) – an initial report on the human clinical trial of the first non-implantable, endovenous approach to deep vein reflux
23. 17:50 - 18:00
  
  Discussion and conclusion
Friday, January 25th: 9:00 - 13:00, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting - Join us for brunch, served from 08:45am until 11:00am

Moderator:

Martin Malina

Panel:

Marc van Sambeek, Thomas Larzon, Olaf Richter, Frank Veith

live from Münster:

Martin Austermann
1. Treatment of ruptured aortic aneurysms – surgery vs. EVAR
2. Why the randomized trials comparing EVAR with open repair for ruptured AAAs are misleading and not generally applicable
3. With adjuncts (Chimney grafts and Onyx) 100% of RAAAs can be treated by EVAR with low 30-day mortality and turn down rate
4. R-EVAR is it feasible, how to deal with abdominal compartemental syndrome, pros and cons
5. Leaking huge AAA and bilateral iliac aneurysms. How vascular plugs help to save life during emergency EVAR
6. Physician modified endograft (PMEG) for EVAR
7. Urgent endovascular treatment of left uretero-iliac fistula in patient with radical cystectomy and ileal conduit urinary diversion
8. An expansion of EVAR by EVAS: a possibility in emergencies
9. Management of infected aneurysms and grafts
10. A successful treatment of an infected saccular aortic aneurysm (PAU) by Chimney- EVAS: Case report
11. Tips and tricks for obtaining supraceliac aortic control with EVAR for ruptured AAAs: it is not simple
12. Trouble shooting and bail-out in FEVAR/BEVAR
13. Nobilizing the chEVAR experience through standardization; How a standard approach improves patient outcomes
14. Emergent use of an arch branch device to treat an ascending aortic rupture with use of a branch-to-branch through-and-through wire

Notice

LINC 2019 presentations

LINC 2019 programme

Room 1 - Main Arena 1

Symposium: Keep on walking: Steps towards successfull PAD treatment

Step by step SFA/pop treatment algorithm

Step by step selection algorithm and clinical decision making through OCT technology

Live case transmission from Leipzig

Supera CFA VMI 1-year follow-up results

Supera in AVF management and 1-year outcomes

Supera in popliteal aneurysm, proof of concept, and clinical outcomes

Live case transmission from Leipzig

Symposium: See clearly, treat optimally: image guided therapy on the rise

Introduction and learning objectives

Next generation pan-vascular suite: optimizing patient management and outcomes

Perfusion angiography for optimizing planning and treatment of diabetic foot

BTK recorded case presentation

Role of IVUS within a “treat optimally” algorithm of care

Innovations at the forefront: a glance at the future of image guided therapy

Live case transmission from Leipzig

Q&A and conclusion

Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs

A look into the methods: merits and limits of meta-analysis

Toxicological aspects and safety profile of Paclitaxel

Event adjudication in clinical trials: how does it work?

PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES

DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme

Long-term safety data of the Lutonix DCB formulation

Long-term safety data from the Stellarex DCB programme

Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme

Patient safety in the Eluvia-DES and Ranger DCB programme

How to proceed to generate more evidence on patient safety with drug-eluting devices

Podium discussion

“To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

FOCUS ON NEW DATA ON DRUG-COATED BALLOONS

First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan

First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?

First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials

First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions

First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-month results of the BIOLUX P-III full cohort

DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series

Stellarex in real world: Interim look from the SAVER registry

FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS

First time data release: Final 12-month results of the Zilverpass-RCT of Zilver PTX vs. bypass

TOBA II Trial (Lutonix or POBA + Tack) – 1-year results

First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease

The Illumina FIH study with a next generation DES – 12-month results

Discussion and conclusion

Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

Endovascular lessons learned in the last decade: what are the remaining challenges?

Live case transmission from Leipzig

Long lesions: primary stenting or DCB first?

Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?

Live case transmission from New York

Dissections: prevent, minimize, or repair

Discussion and conclusion

Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

Welcome and introduction

VIRTUS: Trial design and primary endpoint results

VICI VENOUS STENT: Design attributes & patient outcome

Panel discussion and questions

Complexities of chronic venous disease

Imaging, its central role in planning and guiding intervention

Live case transmission from Galway

Panel discussion and questions

Advanced solutions for complex femoral lesions and critical limb ischemia

True minimally invasive access strategies for complex peripheral interventions

Live case transmission from Leipzig

First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes

First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series

IN.PACT Admiral DCB: a look at long lesion outcomes across trials

From research to practice: how does atherectomy fit in my treatment algorithm

Live case transmission from New York

REALITY: Initial experience

Phoenix atherectomy: technique and real-world evidence

Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on new trials, drug-eluting technologies, and new implants